$10.77
0[0.00%]
At close: Apr 24
$10.77
0[0.00%]
PreMarket: 4:00PM EDT
Biomea Fusion
(NASDAQ:BMEA)Biomea Fusion Stock (NASDAQ:BMEA), Analyst Ratings, Price Targets, Predictions
Biomea Fusion Inc has a consensus price target of $42.54, established from looking at the 48 latest analyst ratings. The last 3 analyst ratings were released from Oppenheimer, JP Morgan, and HC Wainwright & Co. on April 3, 2024, April 2, 2024, and April 1, 2024. With an average price target of $44.67 between Oppenheimer, JP Morgan, and HC Wainwright & Co., there's an implied 314.73% upside for Biomea Fusion Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Oppenheimer
JP Morgan
HC Wainwright & Co.
Truist Securities
Citigroup
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Biomea Fusion
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/03/2024 | BMEA | Buy Now | Biomea Fusion | $10.77 | 549.95% | Oppenheimer | Hartaj Singh | → $70 | Maintains | Outperform | Get Alert |
| 04/02/2024 | BMEA | Buy Now | Biomea Fusion | $10.77 | 29.99% | JP Morgan | Gavin Scott | $51 → $14 | Downgrade | Overweight → Neutral | Get Alert |
| 04/01/2024 | BMEA | Buy Now | Biomea Fusion | $10.77 | 364.25% | HC Wainwright & Co. | Joseph Pantginis | → $50 | Reiterates | Buy → Buy | Get Alert |
| 04/01/2024 | BMEA | Buy Now | Biomea Fusion | $10.77 | 410.68% | Truist Securities | Robyn Karnauskas | → $55 | Reiterates | Buy → Buy | Get Alert |
| 03/06/2024 | BMEA | Buy Now | Biomea Fusion | $10.77 | 364.25% | HC Wainwright & Co. | Joseph Pantginis | → $50 | Reiterates | Buy → Buy | Get Alert |
| 02/06/2024 | BMEA | Buy Now | Biomea Fusion | $10.77 | 410.68% | Truist Securities | Robyn Karnauskas | → $55 | Initiates | → Buy | Get Alert |
| 12/08/2023 | BMEA | Buy Now | Biomea Fusion | $10.77 | 735.65% | Citigroup | Yigal Nochomovitz | → $90 | Reiterates | Buy → Buy | Get Alert |
| 08/01/2023 | BMEA | Buy Now | Biomea Fusion | $10.77 | 299.26% | EF Hutton | Tony Butler | → $43 | Reiterates | Buy → Buy | Get Alert |
| 08/01/2023 | BMEA | Buy Now | Biomea Fusion | $10.77 | 364.25% | HC Wainwright & Co. | Joseph Pantginis | → $50 | Reiterates | Buy → Buy | Get Alert |
| 07/27/2023 | BMEA | Buy Now | Biomea Fusion | $10.77 | 280.69% | Scotiabank | George Farmer | → $41 | Initiates | → Sector Outperform | Get Alert |
| 07/25/2023 | BMEA | Buy Now | Biomea Fusion | $10.77 | 299.26% | EF Hutton | Tony Butler | → $43 | Reiterates | Buy → Buy | Get Alert |
| 07/24/2023 | BMEA | Buy Now | Biomea Fusion | $10.77 | 364.25% | HC Wainwright & Co. | Joseph Pantginis | $50 → $50 | Reiterates | Buy → Buy | Get Alert |
| 07/12/2023 | BMEA | Buy Now | Biomea Fusion | $10.77 | 299.26% | EF Hutton | Tony Butler | → $43 | Reiterates | Buy → Buy | Get Alert |
| 06/26/2023 | BMEA | Buy Now | Biomea Fusion | $10.77 | 159.98% | Jefferies | Eun Yang | $36 → $28 | Downgrade | Buy → Hold | Get Alert |
| 06/26/2023 | BMEA | Buy Now | Biomea Fusion | $10.77 | 317.83% | Piper Sandler | Joseph Catanzaro | $40 → $45 | Maintains | Overweight | Get Alert |
| 06/26/2023 | BMEA | Buy Now | Biomea Fusion | $10.77 | 373.54% | JP Morgan | Gavin Scott | $38 → $51 | Maintains | Overweight | Get Alert |
| 06/26/2023 | BMEA | Buy Now | Biomea Fusion | $10.77 | 735.65% | Citigroup | Yigal Nochomovitz | $53 → $90 | Maintains | Buy | Get Alert |
| 06/26/2023 | BMEA | Buy Now | Biomea Fusion | $10.77 | 197.12% | EF Hutton | Michael King | → $32 | Reiterates | Buy → Buy | Get Alert |
| 06/26/2023 | BMEA | Buy Now | Biomea Fusion | $10.77 | 364.25% | HC Wainwright & Co. | Joseph Pantginis | $37 → $50 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Biomea Fusion (BMEA)?
The latest price target for Biomea Fusion (NASDAQ: BMEA) was reported by Oppenheimer on April 3, 2024. The analyst firm set a price target for $70.00 expecting BMEA to rise to within 12 months (a possible 549.95% upside). 24 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Biomea Fusion (BMEA)?
The latest analyst rating for Biomea Fusion (NASDAQ: BMEA) was provided by Oppenheimer, and Biomea Fusion maintained their outperform rating.
When was the last upgrade for Biomea Fusion (BMEA)?
There is no last upgrade for Biomea Fusion.
When was the last downgrade for Biomea Fusion (BMEA)?
The last downgrade for Biomea Fusion Inc happened on April 2, 2024 when JP Morgan changed their price target from $51 to $14 for Biomea Fusion Inc.
When is the next analyst rating going to be posted or updated for Biomea Fusion (BMEA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biomea Fusion, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biomea Fusion was filed on April 3, 2024 so you should expect the next rating to be made available sometime around April 3, 2025.
Is the Analyst Rating Biomea Fusion (BMEA) correct?
While ratings are subjective and will change, the latest Biomea Fusion (BMEA) rating was a maintained with a price target of $0.00 to $70.00. The current price Biomea Fusion (BMEA) is trading at is $10.77, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.